Skip to main content

Table 1 Cohort selection steps from the Optum® EHR dataset

From: Characterizing patients with rare mucormycosis infections using real-world data

Group selection steps

Patients

% of total patients

% of patients in step 2 (1)

1. All the patients enrolled during Jan 2007–Jun 2019 in Optum®

101,340,454

100.00

2. (1) and with HM and 6 months follow-up

962,428

0.95

100.00

3. (2) and with IA between index and enrollment end date

10,638

0.01

1.11

4. (2) and with IM between index and enrollment end date

1133

0.00

0.12

5. (2) and coinfected with IA and IM within 360 days post-index

161

0.00

0.02

  1. (1) Refers to the overall total number of 101,340,454 patients
  2. (2) Refers to the 962,428 patients with HM and 6 months follow-up
  3. EHR electronic health record, HM hematologic malignancy, IA invasive aspergillosis, IM invasive mucormycosis